Beta Drugs Limited has informed the Exchange regarding the Board meeting to be held on 27th november, 2024 to interalia, transact the following business:-1. To consider & approve the allotment of 100 fully paid-up equity shares of the Company of face value of Rs. 10 each, at a price of Rs 1,653.40 per Equity Share including a premium of Rs. 1,643.40 per Equity Share and 7,07,651 fully paid up unsecured compulsory convertible debentures of the Company ( CCDs ) of face value of Rs. 1,653.40 each under Preferential Issue, pursuant to approval obtained from shareholders in Extra Ordinary General Meeting held on 12th November, 2024.2. To consider, approve & adopt the restated Article of Association of the company, subject to the approval of shareholders of the company in their meeting..